Home Medicine Urinary bisphenol-A levels in children with type 1 diabetes mellitus
Article
Licensed
Unlicensed Requires Authentication

Urinary bisphenol-A levels in children with type 1 diabetes mellitus

  • Tolga İnce ORCID logo EMAIL logo , Aylin Balcı , Siddika Songül Yalçın , Gizem Özkemahlı , Pinar Erkekoglu , Belma Kocer-Gumusel and Kadriye Yurdakök
Published/Copyright: July 5, 2018

Abstract

Background:

Bisphenol-A (BPA) is one of the most abundantly produced chemicals globally. Concerns have been raised about BPA’s possible role in the pathogenesis of type 1 diabetes mellitus (T1DM). The main aim of the current study was to evaluate the possible association between BPA exposure and T1DM. The second aim was to investigate children’s possible BPA exposure routes in Turkey.

Methods:

A total of 100 children aged between 5 and 18 years including 50 children with T1DM and 50 healthy children were included. Urinary BPA levels of all children were measured using high-performance liquid chromatography. Mothers of children enrolled in the study were also requested to complete a survey that included questions on the sociodemographic characteristics, medical history and possible BPA exposure routes of their children.

Results:

In the T1DM group, urinary BPA levels were slightly higher compared to the control group, but this difference was not significant (p=0.510). However, there was an inverse relationship between current urinary BPA levels and birth weight. It was found that the use of plastic kettles and the consumption of dairy products in plastic boxes significantly increased the urinary BPA concentrations in all subjects.

Conclusions:

Although there was no significant association between urinary BPA levels and T1DM, we found an inverse relationship between current urinary BPA levels and birth weight. This finding might be important for prenatal exposure, and further prospective research must be conducted. Also, the use of plastic kettles, which has not been mentioned much in the literature before, was found to be an important exposure route for BPA.


Corresponding author: Tolga İnce, MD, PhD, Assistant Professor, Dokuz Eylul University, Faculty of Medicine, Department of Pediatrics, Social Pediatrics Unit, İnciraltı Mahallesi Mithatpaşa, Street No: 56, Balçova, 35340 İzmir, Turkey, Phone: 090 5053190158

Acknowledgments

We would like to thank the Hacettepe University Faculty of Medicine Department of Pediatric Endocrinology for helping us to take urine samples from children with T1DM.

  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: None declared.

  3. Employment or leadership: None declared.

  4. Honorarium: None declared.

  5. Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

References

1. Vandenberg LN, Hauser R, Marcus M, Olea N, Welshons WV. Human exposure to bisphenol A (BPA). Reprod Toxicol 2007;24:139–77.10.1016/j.reprotox.2007.07.010Search in Google Scholar

2. Ahmadkhaniha R, Mansouri M, Yunesian M, Omidfar K, Jeddi MZ, et al. Association of urinary bisphenol A concentration with type-2 diabetes mellitus. J Environ Health Sci Eng 2014;12:64.10.1186/2052-336X-12-64Search in Google Scholar

3. Huang RP, Liu ZH, Yuan SF, Yin H, Dang Z, et al. Worldwide human daily intakes of bisphenol A (BPA) estimated from global urinary concentration data (2000–2016) and its risk analysis. Environ Pollut 2017;230:143–52.10.1016/j.envpol.2017.06.026Search in Google Scholar

4. Bodin J, Stene LC, Nygaard UC. Can exposure to environmental chemicals increase the risk of diabetes type 1 development? Biomed Res Int 2015;2015:208947.10.1155/2015/208947Search in Google Scholar

5. Pociot F, Lernmark A. Genetic risk factors for type 1 diabetes. Lancet 2016;387:2331–9.10.1016/S0140-6736(16)30582-7Search in Google Scholar

6. DIAMOND Project Group. Incidence and trends of childhood Type 1 diabetes worldwide 1990–1999. Diabet Med 2006;23:857–66.10.1111/j.1464-5491.2006.01925.xSearch in Google Scholar PubMed

7. Melzer D, Rice NE, Lewis C, Henley WE, Galloway TS. Association of urinary bisphenol A concentration with heart disease: evidence from NHANES 2003/06. PLoS One 2010;5:e8673.10.1371/journal.pone.0008673Search in Google Scholar PubMed PubMed Central

8. Rochester JR. Bisphenol A and human health: a review of the literature. Reprod Toxicol 2013;42:132–55.10.1016/j.reprotox.2013.08.008Search in Google Scholar PubMed

9. Sun Q, Cornelis MC, Townsend MK, Tobias DK, Eliassen AH, et al. Association of urinary concentrations of bisphenol A and phthalate metabolites with risk of type 2 diabetes: a prospective investigation in the Nurses’ Health Study (NHS) and NHSII cohorts. Environ Health Perspect 2014;122:616–23.10.1289/ehp.1307201Search in Google Scholar PubMed PubMed Central

10. Legler J, Fletcher T, Govarts E, Porta M, Blumberg B, et al. Obesity, diabetes, and associated costs of exposure to endocrine-disrupting chemicals in the European Union. J Clin Endocrinol Metab 2015;100:1278–88.10.1210/jc.2014-4326Search in Google Scholar PubMed PubMed Central

11. Bodin J, Bølling AK, Samuelsen M, Becher R, Løvik M, et al. Long-term bisphenol A exposure accelerates insulitis development in diabetes-prone NOD mice. Immunopharmacol Immunotoxicol 2013;35:349–58.10.3109/08923973.2013.772195Search in Google Scholar

12. Bodin J, Bølling AK, Becher R, Kuper F, Løvik M, et al. Transmaternal bisphenol A exposure accelerates diabetes type 1 development in NOD mice. Toxicol Sci 2014;137:311–23.10.1093/toxsci/kft242Search in Google Scholar

13. WHO Anthro for personal computers, version 3.2.2, 2011: Software for assessing growth and development of the world’s children. Geneva: WHO, 2010 (http://www.who.int/childgrowth/software/en/).Search in Google Scholar

14. Yang M, Kim SY, Lee SM, Chang SS, Kawamoto T, et al. Biological monitoring of bisphenol A in a Korean population. Arch Environ Contam Toxicol 2003;44:546–51.10.1007/s00244-002-2124-0Search in Google Scholar

15. U.S. Environmental Protection Agency (EPA). 40 CFR Part 136. Guidelines establishing test procedures for the analysis of pollutants, 2012. Available at: http://www.epa.gov/region9/qa/pdfs/40cfr136_03.pdf. Accessed: 22 July 2017.Search in Google Scholar

16. Jen JF, Hsiao SL, Liu KH. Simultaneous determination of uric acid and creatinine in urine by an eco-friendly solvent-free high performance liquid chromatographic method. Talanta 2000;58:711–7.10.1016/S0039-9140(02)00377-6Search in Google Scholar

17. Casals-Casas C, Desvergne B. Endocrine disruptors: from endocrine to metabolic disruption. Annu Rev Physiol 2011;73:135–62.10.1146/annurev-physiol-012110-142200Search in Google Scholar PubMed

18. Volkel W, Colnot T, Csanady GA, Filser JG, Dekant W. Metabolism and kinetics of bisphenol A in humans at low doses following oral administration. Chem Res Toxicol 2002;15:1281–7.10.1021/tx025548tSearch in Google Scholar PubMed

19. Ye X, Wong LY, Bishop AM, Calafat AM. Variability of urinary concentrations of bisphenol A in spot samples, first morning voids, and 24-hour collections. Environ Health Perspect 2011;119:983–8.10.1289/ehp.1002701Search in Google Scholar PubMed PubMed Central

20. Liao C, Kannan K. Determination of free and conjugated forms of bisphenol A in human urine and serum by liquid chromatography-tandem mass spectrometry. Environ Sci Technol 2012;46:5003–9.10.1021/es300115aSearch in Google Scholar PubMed

21. ECB. European Chemicals Bureau, European Union risk assessment report 4,4′-ısopropylidenediphenol(bisphenol-A). Office for Official Publications of the European Communities, 2003. Einecs No: 201-245–8.Search in Google Scholar

22. World Health Organization. Human biomonitoring: facts and figures. Copenhagen: WHO Regional Office for Europe, 2015. Available at: http://www.euro.who.int/__data/assets/pdf_file/0020/276311/Human-biomonitoring-facts-figures-en.pdf. Accessed: 19 July 2017.Search in Google Scholar

23. CDC. Fourth National Report on Human Exposure to Environmental Chemicals, Updated Tables. Available at: https://www.cdc.gov/exposurereport/pdf/FourthReport_UpdatedTables_Volume1_Jan2017.pdf. Accessed: 10 July 2017.Search in Google Scholar

24. Ellialtı E. Bisphenol-A exposure and urinary bisphenol-A levels in exogen obese children. Dissertation, Ankara, Turkey: Hacettepe University, 2011.Search in Google Scholar

25. Durmaz E, Aşçı A, Erkekoğlu P, Akçurin S, Gümüşel BK, et al. Urinary bisphenol A levels in girls with idiopathic central precocious puberty. J Clin Res Pediatr Endocrinol 2014;6:16–21.10.4274/Jcrpe.1220Search in Google Scholar PubMed PubMed Central

26. Battal D. Determination of bisphenol A level in Mersin population. Dissertation, Mersin, Turkey: University of Mersin, 2012.Search in Google Scholar

27. Rancière F, Lyons JG, Loh VH, Botton J, Galloway T, et al. Bisphenol A and the risk of cardiometabolic disorders: a systematic review with meta-analysis of the epidemiological evidence. Environ Health 2015;14:46.10.1186/s12940-015-0036-5Search in Google Scholar PubMed PubMed Central

28. Atabek ME. Endocrine disruptors and fulminant type 1 diabetes: is there a link? J Pediatr Endocrinol Metab 2012;25:387–8.10.1515/jpem-2011-0482Search in Google Scholar PubMed

29. Supornsilchai V, Jantarat C, Nosoognoen W, Pornkunwilai S, Wacharasindhu S, et al. Increased levels of bisphenol A (BPA) in Thai girls with precocious puberty. J Pediatr Endocrinol Metab 2016;29:1233–9.10.1515/jpem-2015-0326Search in Google Scholar PubMed

30. Cetkovic-Cvrlje M, Thinamany S, Bruner KA. Bisphenol A (BPA) aggravates multiple low-dose streptozotocin-induced Type 1 diabetes in C57BL/6 mice. J Immunotoxicol 2017;14:160–8.10.1080/1547691X.2017.1334722Search in Google Scholar PubMed

31. Weldingh NM, Jørgensen-Kaur L, Becher R, Holme JA, Bodin J, et al. Bisphenol A is more potent than phthalate metabolites in reducing pancreatic β-cell function. Biomed Res Int 2017;2017:4614379.10.1155/2017/4614379Search in Google Scholar PubMed PubMed Central

32. Rubin BS, Murray MK, Damassa DA, King JC, Soto AM. Perinatal exposure to low doses of bisphenol A affects body weight, patterns of estrous cyclicity, and plasma LH levels. Environ Health Perspect 2001;109:675–80.10.1289/ehp.01109675Search in Google Scholar PubMed PubMed Central

33. Markey B, Henare K, Thorstensen EB, Eric B, Ponnampalam AP, et al. Transfer of bisphenol A across the human placenta. Am J Obstet Gynecol 2010;202:393e1–7.10.1016/j.ajog.2010.01.025Search in Google Scholar PubMed

34. Chou WC, Chen JL, Lin CF, Chen YC, Shih FC, et al. Biomonitoring of bisphenol A concentrations in maternal and umbilical cord blood in regard to birth outcomes and adipokine expression: a birth cohort study in Taiwan. Environ Health 2011;10:94.10.1186/1476-069X-10-94Search in Google Scholar PubMed PubMed Central

35. Huo W, Xia W, Wan Y, Zhang B, Zhou A, et al. Maternal urinary bisphenol A levels and infant low birth weight: a nested case-control study of the Health Baby Cohort in China. Environ Int 2015;85:96–103.10.1016/j.envint.2015.09.005Search in Google Scholar PubMed

36. Veiga-Lopez A, Kannan K, Liao C, Ye W, Domino SE, et al. Gender-specific effects on gestational length and birth weight by early pregnancy BPA exposure. J Clin Endocrinol Metab 2015;100:E1394–403.10.1210/jc.2015-1724Search in Google Scholar PubMed PubMed Central

37. Miao M, Yuan W, Zhu G, He X, Li DK. In utero exposure to bisphenol-A and its effect on birth weight of offspring. Reprod Toxicol 2011;321:64–8.10.1016/j.reprotox.2011.03.002Search in Google Scholar PubMed

38. Olea N, Arrebola JP, Taoufiki J, Fernández-Valades R, Prada R, et al. Alkylphenols and bisphenol-A and its chlorinated derivatives in adipose tissue of children. In: Kungolos AG, Brebbia CA, Zamorano M, editors. Environmental Toxicology II WIT Transactions on Ecology and the Environment Granada, Spain: Wessex Institute, 2008.10.2495/ETOX080141Search in Google Scholar

39. Rezg R, El-Fazaa S, Gharbi N, Mornagui B. Bisphenol A and human chronic diseases: current evidences, possible mechanisms, and future perspectives. Environ Int 2014;64:83–90.10.1016/j.envint.2013.12.007Search in Google Scholar PubMed

40. Cooper JE, Kendig EL, Belcher SM. Assessment of bisphenol A released from reusable plastic, aluminum and stainless-steel water bottles. Chemosphere 2011;85:943–7.10.1016/j.chemosphere.2011.06.060Search in Google Scholar PubMed PubMed Central

41. Brede C, Fjeldal P, Skjevrak I, Herikstad H. Increased migration levels of bisphenol A from polycarbonate baby bottles after dishwashing, boiling and brushing. Food Addit Contam 2003;20:684–9.10.1080/0265203031000119061Search in Google Scholar PubMed

42. EFSA. Opinion of the scientific panel on food additives, flavourings, processing aids and materials in contact with food (AFC) on request from the Commission related to 2,2-bis(hydroxyphenol)propane (bisphenol A). Question number EFSA-Q-2005-100, adopted on 29 November 2006. EFSA J 2006;428:1–75. Available from: http://www.efsa.europa.eu/en/efsajournal/doc/428.pdf. Accessed: 12 December 2017.10.2903/j.efsa.2007.428Search in Google Scholar

43. EFSA: Scientific opinion on the risks to public health related to the presence of bisphenol A (BPA) in foodstuffs: Part II – Toxicological assessment and risk characterisation. EFSA J 2015;13:3978.10.2903/j.efsa.2015.3978Search in Google Scholar

44. Lim DS, Kwack SJ, Kim KB, Kim HS, Lee BM. Potential risk of bisphenol A migration from polycarbonate containers after heating, boiling, and microwaving. J Toxicol Environ Health A 2009;72:1285–91.10.1080/15287390903212329Search in Google Scholar PubMed

Received: 2018-03-24
Accepted: 2018-06-11
Published Online: 2018-07-05
Published in Print: 2018-08-28

©2018 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Original Articles
  3. Urinary bisphenol-A levels in children with type 1 diabetes mellitus
  4. The relationship between metabolic syndrome, cytokines and physical activity in obese youth with and without Prader-Willi syndrome
  5. Association of anthropometric measures and cardio-metabolic risk factors in normal-weight children and adolescents: the CASPIAN-V study
  6. The effect of obesity and insulin resistance on macular choroidal thickness in a pediatric population as assessed by enhanced depth imaging optical coherence tomography
  7. Hereditary 1,25-dihydroxyvitamin D-resistant rickets (HVDRR): clinical heterogeneity and long-term efficacious management of eight patients from four unrelated Arab families with a loss of function VDR mutation
  8. Long-term thyroid disorders in pediatric survivors of hematopoietic stem cell transplantation after chemotherapy-only conditioning
  9. Screening for autoimmune thyroiditis and celiac disease in minority children with type 1 diabetes
  10. Resistance exercise alone improves muscle strength in growth hormone deficient males in the transition phase
  11. Sequential measurements of IGF-I serum concentrations in adolescents with Laron syndrome treated with recombinant human IGF-I (rhIGF-I)
  12. Symptomatic Rathke cleft cyst in paediatric patients – clinical presentations, surgical treatment and postoperative outcomes – an analysis of 38 cases
  13. Molecular genetics of tetrahydrobiopterin deficiency in Chinese patients
  14. Single center experience of biotinidase deficiency: 259 patients and six novel mutations
  15. Next-generation sequencing as a second-tier diagnostic test for newborn screening
  16. Case Reports
  17. Thyroid storm after choking
  18. Three new Brazilian cases of 17α-hydroxylase deficiency: clinical, molecular, hormonal, and treatment features
  19. Diazoxide toxicity in a child with persistent hyperinsulinemic hypoglycemia of infancy: mixed hyperglycemic hyperosmolar coma and ketoacidosis
  20. Refractory hypoglycemia in a pediatric patient with desmoplastic small round cell tumor
Downloaded on 31.12.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jpem-2018-0141/html
Scroll to top button